期刊文献+

应用Ussing Chamber技术评价芹菜素与柚皮素经大鼠肠黏膜透过特征 被引量:8

Permeabilities of Apigenin and Naringenin via Different Rat Intestinal Mucosa in Ussing Chamber
原文传递
导出
摘要 目的研究芹菜素与柚皮素经大鼠空肠、回肠与结肠黏膜的区段透过特征。方法采用体外Ussing Chamber方法,分别评价50μmol.L-1芹菜素及柚皮素经空肠、回肠和结肠黏膜经时吸收方向(M-S)与分泌方向(S-M)的累计透过率和表观渗透系数(Papp),芹菜素与柚皮素在接收池的样品浓度用HPLC测定。结果芹菜素与柚皮素在结肠的透过性显著高于空肠(P<0.01)和回肠(P<0.05)。比较M-S方向和S-M方向的透过性发现,芹菜素空肠与回肠经两个方向的透过性无显著差异,但经结肠透过时,吸收方向的透过性显著高于分泌方向的透过性(P<0.01);柚皮素在空肠、回肠及结肠黏膜经两个方向的透过性均无显著差异。结论芹菜素与柚皮素在大鼠肠黏膜中的透过性存在区段性差异,结肠部位吸收最好。芹菜素与柚皮素除被动扩散外,可能受到肠黏膜转运体的调控。 OBJECTIVE To investigate the permeabilities of apigenin and naringenin across the jejunal,ileal and colonic membranes in rats.METHODS The cumulative permeation amounts and the permeabilities(Papp) of apigenin and naringenin via rat intestinal membranes in both absorption(M-S) and secretion(S-M) direction at the concentration of 50 μmol·L-1 were evaluated by the method of Ussing Chamber.The concentrations of apigenin and naringenin in the receptor samples were determined by HPLC.RESULTS The permeabilities of apigenin and naringenin across the colonic membrane were significantly higher than those across jejunal(P0.01) or ileal(P0.05) membrane.And the permeability of apigenin in the colonic membrane from the mucosal to serosal direction was significantly greater than that from the mucosal to serosal direction(P0.01).CONCLUSION The permeabilities of apigenin and naringenin across the jejunum,ileum and colon in rats exhibit regional differences,which show the highest in the colon.In addition,the transport of apigenin and naringenin may be regulated by some transporters besides passive diffusion.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第20期1581-1586,共6页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81073061) 广东省科技攻关项目(2010B030700014) 广州市白云科技计划项目(2009-sz-36)
关键词 芹菜素 柚皮素 Ussing Chamber技术 肠黏膜 apigenin naringenin Ussing Chamber intestinal mucosa
  • 相关文献

参考文献8

二级参考文献43

  • 1贺云霞,孙进,程刚.多药耐药性P-糖蛋白在药物肠道吸收中的作用[J].沈阳药科大学学报,2004,21(5):389-393. 被引量:23
  • 2杨振,秦环龙.Ussing chamber在肠道屏障功能研究中的进展[J].肠外与肠内营养,2006,13(4):233-236. 被引量:10
  • 3PERLOFF M D, VON MOLTKE L L, MARCHAND J F, et al. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein ( MRP1 ) expression, and drug transporter-mediated activity in a human intestinal cell line [J]. J Pharm Sci, 2001, 90(11): 1829-1837.
  • 4KRISHNA R, MAYER L D. Multidrug resistance(MDR) in cancer mechanisms, reversal using modulators of MDR and the role of MDR in influencing the pharmacokinetics of anticancer drugs [ J ]. Eru J Pharm Sci , 2000, 11(4) : 265-283.
  • 5MOLDEN E. P-glycoprotein-a pump of significance for drug response [ J ]. Tidsskr Nor Laegeforen, 2004, 124 ( 22 ) : 2921- 2923.
  • 6SAKAEDA T, NAKAMURA T, OKUMURA K. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy [J]. Curr Top Med Chem, 2004, 4(13) :1385-1398.
  • 7Ch.P(2005)Vol I(中国药典2005年版一部)[S].2005:109.
  • 8ZHENG W F, GAO X W, QI G, et al. Antitumor activity of daphnodorins from Daphne genkwa roots [ J ]. Int lmmunopharmacol, 2007,7 ( 2 ) : 128-134.
  • 9ZHENG S X, LI X N, ZHANG F H, et al. Preparation of yuanhuaeine and relative daphne diterpeneesters from Daphne genkwa and structure activity relationship of potent inhibitory activity against DNA topoisomerase I [ J ]. Bioorg Med Chem, 2006, 14 ( 1 ) :3888-3895.
  • 10SHEN Q, LIN Y L,TAHAHIRO H,et al. Modulation of Intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies [ J ]. Int JPharm, 2006, 313(1-2) : 49-56.

共引文献24

同被引文献119

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部